Drug Shortage Report for SEROQUEL XR

Last updated on 2017-04-27 History
Report ID 2471
Drug Identification Number 02300206
Brand name SEROQUEL XR
Common or Proper name quetiapine fumarate extended-release tablets
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) QUETIAPINE
Strength(s) 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 60 tablets
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-04-24
Actual start date 2017-04-24
Estimated end date 2017-04-26
Actual end date 2017-04-26
Shortage status Resolved
Updated date 2017-04-27
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected].

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-04-27 English Compare
v13 2017-04-26 French Compare
v12 2017-04-26 English Compare
v11 2017-04-26 English Compare
v10 2017-04-26 French Compare
v9 2017-04-26 English Compare
v8 2017-04-25 English Compare
v7 2017-04-10 French Compare
v6 2017-04-10 English Compare
v5 2017-04-10 English Compare
v4 2017-04-10 English Compare
v3 2017-04-06 French Compare
v2 2017-04-06 English Compare
v1 2017-03-14 English Compare

Showing 1 to 14 of 14